Medici List crest
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

ArriVent BioPharma, Inc.

CIK: 18682792 Annual ReportsLatest: 2026-03-05

10-K / March 5, 2026

Revenue:N/A
Income:-$166,308,000

10-K / March 28, 2024

Revenue:N/A
Income:-$69,300,000

10-K / March 5, 2026

Unnamed Company

Document: PART I of a Form 10-K

Sections and page numbers:

  • Item 1. Business — page 5
  • Item 1A. Risk Factors — page 62
  • Item 1B. Unresolved Staff Comments — page 136
  • Item 1C. Cybersecurity — page 136
  • Item 2. Properties — page 138
  • Item 3. Legal Proceedings — page 138
  • Item 4. Mine Safety Disclosures — page 139

Inferences from the structure:

  • The document follows the Form 10-K annual report format.
  • The inclusion of Mine Safety Disclosures indicates the company operates in an industry where mine safety is relevant (for example, mining or related sectors).

Next step:

  • Please provide the text from Item 1. Business (and any other sections you want included). With that content I can produce a detailed markdown summary covering the company’s operations and key metrics (customers, employees, revenue, income).